Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 40,469Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MSN Laboratories Private Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Tides Europe
Not Confirmed
arrow
arrow
Tides Europe
Not Confirmed

Micronized dabrafenib mesylate

Registrant Name : Kukjeon Pharmaceutical Co., Ltd.

Registration Date : 2025-07-10

Registration Number : Su173-60-ND

Manufacturer Name : MSN Laboratories Private Lim...

Manufacturer Address : (Unit-ll) Sy. No. 50, 53, 53/A, 54 & 54/A, Kardanur (Village), Patancheru (Mandal), S...

blank

Looking for 1195768-06-9 / Dabrafenib Mesylate API manufacturers, exporters & distributors?

Dabrafenib Mesylate manufacturers, exporters & distributors 1

73

PharmaCompass offers a list of Dabrafenib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dabrafenib Mesylate manufacturer or Dabrafenib Mesylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dabrafenib Mesylate manufacturer or Dabrafenib Mesylate supplier.

PharmaCompass also assists you with knowing the Dabrafenib Mesylate API Price utilized in the formulation of products. Dabrafenib Mesylate API Price is not always fixed or binding as the Dabrafenib Mesylate Price is obtained through a variety of data sources. The Dabrafenib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Dabrafenib Mesylate

Synonyms

1195768-06-9, Dabrafenib (mesylate), Gsk 2118436b, Dabrafenib mesilate, Dabrafenib mesylate [usan], Unii-b6dc89i63e

Cas Number

1195768-06-9

Unique Ingredient Identifier (UNII)

B6DC89I63E

About Dabrafenib Mesylate

Dabrafenib Mesylate is the mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations.

Dabrafenib Manufacturers

A Dabrafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dabrafenib, including repackagers and relabelers. The FDA regulates Dabrafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dabrafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Dabrafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Dabrafenib Suppliers

A Dabrafenib supplier is an individual or a company that provides Dabrafenib active pharmaceutical ingredient (API) or Dabrafenib finished formulations upon request. The Dabrafenib suppliers may include Dabrafenib API manufacturers, exporters, distributors and traders.

click here to find a list of Dabrafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Dabrafenib KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Dabrafenib Drug Master File in Korea (Dabrafenib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dabrafenib. The MFDS reviews the Dabrafenib KDMF as part of the drug registration process and uses the information provided in the Dabrafenib KDMF to evaluate the safety and efficacy of the drug.

After submitting a Dabrafenib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dabrafenib API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Dabrafenib suppliers with KDMF on PharmaCompass.

Dabrafenib Manufacturers | Traders | Suppliers

Dabrafenib Manufacturers, Traders, Suppliers 1
74

We have 1 companies offering Dabrafenib

Get in contact with the supplier of your choice:

  1. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.